Reply-Reference-Cited by-同舟云学术

Published:2002-06 Issue:6 Volume:35 Page:1550-1551
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chalasani Naga,Gorski J. Christopher,Patel Nilesh H.,Hall Stephen D.,Galinsky Raymond E.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1053/jhep.2002.33827/fullpdf

Reference7 articles.

1. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts;Chalasani;Hepatology,2001

2. Concepts basic to pharmacokinetics;Tozer;Pharmacol Ther,1981

3. Role of p-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics;Wacher;J Pharm Sci,1998

4. Prediction of ketoconazole interaction with midazolam, alprazolam and triazolam: incorporating population variability;Yang;Br J Clin Pharmacol,2001

5. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt;Huonker;Gut,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling;The Journal of Clinical Pharmacology;2020-02-20

2. First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans;Biotechnology and Bioengineering;2014-06-24

3. Physiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction;Drug Metabolism and Disposition;2011-06-01

4. Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data;Drug Metabolism and Disposition;2010-04-05